Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 gro-beta, a -C-X-C- chemokine, is an angiogenesis inhibitor that suppresses the growth of Lewis lung carcinoma in mice.

Literature DB >> 7500052

gro-beta, a -C-X-C- chemokine, is an angiogenesis inhibitor that suppresses the growth of Lewis lung carcinoma in mice.

Y Cao¹, C Chen, J A Weatherbee, M Tsang, J Folkman.

Abstract

We have found that two chemokines, recombinant gro-alpha and gro-beta, specifically inhibit growth factor-stimulated proliferation of capillary endothelial cells in a dose-dependent manner, whereas gro-gamma has no inhibitory effect. In vivo, gro-beta inhibits blood vessel formation in the chicken chorioallantoic membrane assay. It is sufficiently potent to effectively suppress basic fibroblast growth factor-induced corneal neovascularization after systemic administration in mice. Further, gro-beta significantly inhibits the growth of murine Lewis lung carcinoma in syngeneic C57B16/J and immunodeficient nude mice without toxicity. In vitro, Lewis lung carcinoma cells are completely insensitive to recombinant gro-beta at high concentrations that significantly inhibit endothelial cell proliferation. This finding supports the conclusion that gro-beta inhibits Lewis lung tumor growth by suppression of tumor-induced neovascularization.

Entities: Disease Gene Species

Mesh：

Substances：

Year: 1995 PMID： 7500052 PMCID： PMC2192268 DOI： 10.1084/jem.182.6.2069

Source DB: PubMed Journal: J Exp Med ISSN： 0022-1007 Impact factor: 14.307

25 in total

1. Inhibition of angiogenesis by recombinant human platelet factor-4 and related peptides.

Authors: T E Maione; G S Gray; J Petro; A J Hunt; A L Donner; S I Bauer; H F Carson; R J Sharpe
Journal: Science Date: 1990-01-05 Impact factor: 47.728

2. The three-dimensional structure of bovine platelet factor 4 at 3.0-A resolution.

Authors: R St Charles; D A Walz; B F Edwards
Journal: J Biol Chem Date: 1989-02-05 Impact factor: 5.157

3. Interaction of platelet factor four with cultured vascular endothelial cells.

Authors: M E Rybak; M A Gimbrone; P F Davies; R I Handin
Journal: Blood Date: 1989-05-01 Impact factor: 22.113

4. Control of angiogenesis with synthetic heparin substitutes.

Authors: J Folkman; P B Weisz; M M Joullié; W W Li; W R Ewing
Journal: Science Date: 1989-03-17 Impact factor: 47.728

5. Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells.

Authors: N Ferrara; W J Henzel
Journal: Biochem Biophys Res Commun Date: 1989-06-15 Impact factor: 3.575

6. Platelet factor 4 blocks the binding of basic fibroblast growth factor to the receptor and inhibits the spontaneous migration of vascular endothelial cells.

Authors: Y Sato; M Abe; R Takaki
Journal: Biochem Biophys Res Commun Date: 1990-10-30 Impact factor: 3.575

7. Growth inhibition of murine melanoma and human colon carcinoma by recombinant human platelet factor 4.

Authors: R J Sharpe; H R Byers; C F Scott; S I Bauer; T E Maione
Journal: J Natl Cancer Inst Date: 1990-05-16 Impact factor: 13.506

8. A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin.

Authors: D J Good; P J Polverini; F Rastinejad; M M Le Beau; R S Lemons; W A Frazier; N P Bouck
Journal: Proc Natl Acad Sci U S A Date: 1990-09 Impact factor: 11.205

9. Long-term culture of capillary endothelial cells.

Authors: J Folkman; C C Haudenschild; B R Zetter
Journal: Proc Natl Acad Sci U S A Date: 1979-10 Impact factor: 11.205

10. Interleukin-8 as a macrophage-derived mediator of angiogenesis.

Authors: A E Koch; P J Polverini; S L Kunkel; L A Harlow; L A DiPietro; V M Elner; S G Elner; R M Strieter
Journal: Science Date: 1992-12-11 Impact factor: 47.728

28 in total

1. Regulation of local host-mediated anti-tumor mechanisms by cytokines: direct and indirect effects on leukocyte recruitment and angiogenesis.

Authors: M Watanabe; K L McCormick; K Volker; J R Ortaldo; J M Wigginton; M J Brunda; R H Wiltrout; W E Fogler
Journal: Am J Pathol Date: 1997-05 Impact factor: 4.307

2. Chemokines induce the cellular migration of MCF-7 human breast carcinoma cells: subpopulations of tumour cells display positive and negative chemotaxis and differential in vivo growth potentials.

Authors: S J Prest; R C Rees; C Murdoch; J F Marshall; P A Cooper; M Bibby; G Li; S A Ali
Journal: Clin Exp Metastasis Date: 1999-07 Impact factor: 5.150

Review 3. Mathematical modeling of tumor-induced angiogenesis.

Authors: Nikos V Mantzaris; Steve Webb; Hans G Othmer
Journal: J Math Biol Date: 2004-02-06 Impact factor: 2.259

4. Serum GROβ: a potential tumor-associated biomarker for colorectal cancer.

Authors: Zhaoxu Zheng; Min Zheng; Jianjun Bi; Qiang Feng; Zhigang Yue; Yanqiu Zhou; Wanning Hu; Haizeng Zhang; Hongjun Gao
Journal: Int J Clin Exp Med Date: 2015-02-15

5. Differential gene expression during capillary morphogenesis in a microcarrier-based three-dimensional in vitro model of angiogenesis with focus on chemokines and chemokine receptors.

Authors: Xi-Tai Sun; Min-Yue Zhang; Chang Shu; Qiang Li; Xiao-Gui Yan; Ni Cheng; Yu-Dong Qiu; Yi-Tao Ding
Journal: World J Gastroenterol Date: 2005-04-21 Impact factor: 5.742

6. A systematic methodology for proteome-wide identification of peptides inhibiting the proliferation and migration of endothelial cells.

Authors: Emmanouil D Karagiannis; Aleksander S Popel
Journal: Proc Natl Acad Sci U S A Date: 2008-09-09 Impact factor: 11.205